Key result
Early palliative integration and advance care planning safeguard patient preferences during LVAD deactivation.
Why the study?
The unique nature of left ventricular assist devices in prolonging life raises complex ethical questions regarding patient identity, device ontology, and treatment categorization. Consequently, clinicians require a deeper understanding and an introductory framework to navigate requests for LVAD deactivation, particularly in controversial situations without obvious medical or device-related complications.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“At the time there was a lot of recognition in the advanced heart failure community that LVAD didn't always go well and people needed to be prepared for that. I think most people felt that including palliative care was logical." — Larry Allen, MD, MHS, FACC”
Provides an introductory ethical framework and best practices—including pre-implant advance care planning and early palliative care integration—for managing requests for LVAD deactivation in advanced heart failure.
Left ventricular assist devices (LVADs) have become an increasingly common advanced therapy in patients with severe symptomatic heart failure. Their unique nature in prolonging life through incorporation into the circulatory system raises ethical questions regarding patient identity and values, device ontology, and treatment categorization; approaching requests for LVAD deactivation requires consideration of these factors, among others. To that end, clinicians would benefit from a deeper understanding of: 1) the history and nature of LVADs; 2) the wider context of device deactivation and associated ethical considerations; and 3) an introductory framework incorporating best practices in requests for LVAD deactivation (specifically in controversial situations without obvious medical or device-related complications). In such decisions, heart failure teams can safeguard patient preferences without compromising ethical practice through more explicit advance care planning before LVAD implantation, early integration of hospice and palliative medicine specialists (maintained throughout the disease process), and further research interrogating behaviors and attitudes related to LVAD deactivation.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Zaidi et al. (2023) conducted a review in Severe symptomatic heart failure with left ventricular assist devices (LVADs). Left ventricular assist device (LVAD) deactivation and advance care planning was evaluated. LVAD deactivation requests require ethical frameworks, explicit pre-implant advance care planning, and early palliative medicine integration to safeguard patient preferences.
Synapse has enriched 10 related papers. Consider them for comparative context: